SCHEMBL5316623

SCHEMBL5316623

NNc1ccc2c(=O)n(Cc3ccc4ccccc4c3)ccc2c1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP19A1 P11511 1/20 0.42
FLT1 P17948 1/20 0.40
KDR P35968 1/20 0.40
GAA P10253 1/20 0.40
ROCK1 Q13464 2/20 0.39
ROCK2 O75116 1/20 0.39
TDP1 Q9NUW8 2/20 0.38
KMT2A Q03164 2/20 0.38
MEN1 O00255 1/20 0.38
RXFP1 Q9HBX9 1/20 0.38
CA1 P00915 1/20 0.38
CA2 P00918 1/20 0.38
DAO P14920 1/20 0.37
POLB P06746 2/20 0.37
NLRP3 Q96P20 1/20 0.37
ALDH1A1 P00352 1/20 0.36
LMNA P02545 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
MAPK14 Q16539 1/20 0.36
ACHE P22303 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5311595 0.87 ACHE (0.44) RXFP1POLBLMNAMAPK14ACHE
SCHEMBL5310870 0.82 MAPT (0.47) GAAKMT2AMEN1RXFP1ALDH1A1
SCHEMBL5313061 0.82 MAPT (0.49) ROCK1ROCK2KMT2AMEN1RXFP1
SCHEMBL5309410 0.80 ALDH1A1 (0.43) ROCK1ROCK2ALDH1A1LMNAHTR6
SCHEMBL5313944 0.78 THRB (0.44) KMT2AMEN1RXFP1POLBALDH1A1
SCHEMBL5312433 0.78 HSP90AB1 (0.58) L3MBTL1ACHE
SCHEMBL5332390 0.77 KDM4E (0.44) KMT2AMEN1ALDH1A1LMNAKLKB1
SCHEMBL5311119 0.76 FLT3 (0.45) TDP1KMT2AMEN1RXFP1POLB
SCHEMBL5313911 0.76 LMNA (0.46) POLBLMNA
SCHEMBL5311297 0.75 LMNA (0.48) GAAKMT2AMEN1ALDH1A1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2007053352-A2 PYRROLOQUINOLINONE DERIVATIVES AS 5-HYDROXYTRYPTAMINE-6 LIGANDS WYETH (US) 2007-05-10 WO disclosed
US-20070099911-A1 Pyrroloquinolinone derivatives as 5-hydroxytryptamine-6 ligands WYETH (US) 2007-05-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070099911-A1 Pyrroloquinolinone derivatives as 5-hydroxytryptamine-6 ligands HTR6, HTR5A, HTR2C CYP19A1 1935/4885FLT1 1472/4885KDR 1224/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.